These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7522119)

  • 21. Pioglitazone and dexamethasone induce adipogenesis in D1 bone marrow stromal cell line, but not through the peroxisome proliferator-activated receptor-gamma pathway.
    Hung SH; Yeh CH; Huang HT; Wu P; Ho ML; Chen CH; Wang C; Chao D; Wang GJ
    Life Sci; 2008 Mar; 82(11-12):561-9. PubMed ID: 18272184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of murine osteosarcoma cell proliferation by glucocorticoid.
    Yamamoto T; Nishiguchi M; Inoue N; Goto HG; Kudawara I; Ueda T; Yoshikawa H; Tanigaki Y; Nishizawa Y
    Anticancer Res; 2002; 22(6C):4151-6. PubMed ID: 12553047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FK506 suppresses the stimulation of matrix metalloproteinase 13 synthesis by interleukin-1beta in rheumatoid synovial fibroblasts.
    Migita K; Miyashita T; Maeda Y; Aoyagi T; Kawabe Y; Nakamura M; Yatsuhashi H; Ishibashi H; Eguchi K
    Immunol Lett; 2005 May; 98(2):194-9. PubMed ID: 15860218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FKBP12 is not required for the modulation of transforming growth factor beta receptor I signaling activity in embryonic fibroblasts and thymocytes.
    Bassing CH; Shou W; Muir S; Heitman J; Matzuk MM; Wang XF
    Cell Growth Differ; 1998 Mar; 9(3):223-8. PubMed ID: 9543388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-classical androgenic actions of RU38486 in androgen-responsive Shionogi carcinoma 115 cells in serum-free culture.
    Lu J; Matsumoto K; Nishizawa Y; Tanaka A; Hirose T; Sato B
    J Steroid Biochem Mol Biol; 1991 Sep; 39(3):329-35. PubMed ID: 1911422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FK506 inhibits tumour necrosis factor-alpha secretion in human keratinocytes via regulation of nuclear factor-kappaB.
    Lan CC; Yu HS; Wu CS; Kuo HY; Chai CY; Chen GS
    Br J Dermatol; 2005 Oct; 153(4):725-32. PubMed ID: 16181452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporin A and FK-506 in inhibition of rat Ito cell activation in vitro.
    Ikeda H; Fujiwara K
    Hepatology; 1995 Apr; 21(4):1161-6. PubMed ID: 7535735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of growth by the antihormone RU486 in different hepatoma cell lines.
    Chasserot-Golaz S; Beck G; Venetianer A
    Mol Cell Endocrinol; 1991 Dec; 82(2-3):151-8. PubMed ID: 1794606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the anti-progestin and anti-glucocorticoid steroid RU486 on cell proliferation in oviductal embryos of lactating mice.
    McRae AC
    J Reprod Fertil; 1994 Jan; 100(1):307-13. PubMed ID: 8182605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chlamydia pneumoniae growth inhibition in cells by the steroid receptor antagonist RU486 (mifepristone).
    Yamaguchi H; Kamiya S; Uruma T; Osaki T; Taguchi H; Hanawa T; Fukuda M; Kawakami H; Goto H; Friedman H; Yamamoto Y
    Antimicrob Agents Chemother; 2008 Jun; 52(6):1991-8. PubMed ID: 18347111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiproliferative action of the steroid RU486 in cultured human lymphoma cells.
    Schuster C; Chasserot-Golaz S; Beck G
    Cancer Lett; 1993 Jul; 71(1-3):43-50. PubMed ID: 8364897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a steroidal antiinflammatory agent on the proliferation of mouse embryo fibroblasts in culture.
    Durant S; Duval D; Homo-Delarche F
    Agents Actions; 1986 Jan; 17(3-4):318-9. PubMed ID: 3962775
    [No Abstract]   [Full Text] [Related]  

  • 33. The antisteroid RU486: its cellular and molecular mode of action.
    Baulieu EE
    Trends Endocrinol Metab; 1991; 2(6):233-9. PubMed ID: 18411188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the mechanism of action of RU486.
    Baulieu EE
    Ann N Y Acad Sci; 1991; 626():545-60. PubMed ID: 2058972
    [No Abstract]   [Full Text] [Related]  

  • 35. [Inhibition of the anti-glucocorticosteroid effect of RU486 on the growth of mouse fibroblasts in culture by the immunosuppressor kf506]].
    Jung-Testas I; Delespierre B; Baulieu EE
    C R Acad Sci III; 1993 Dec; 316(12):1495-9. PubMed ID: 7522119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mifepristone (RU486) protects Purkinje cells from cell death in organotypic slice cultures of postnatal rat and mouse cerebellum.
    Ghoumari AM; Dusart I; El-Etr M; Tronche F; Sotelo C; Schumacher M; Baulieu EE
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7953-8. PubMed ID: 12810951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding studies of RU486 in different Reuber hepatoma variants.
    Chasserot-Golaz S; Beck G
    Receptor; 1993; 3(1):31-7. PubMed ID: 8348081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective effects of tacrolimus (FK506) in a model of ischemic cortical cell cultures: role of glutamate uptake and FK506 binding protein 12 kDa.
    Labrande C; Velly L; Canolle B; Guillet B; Masmejean F; Nieoullon A; Pisano P
    Neuroscience; 2006; 137(1):231-9. PubMed ID: 16289353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [FK506: an immunosuppressor for the '90's?].
    López-Gil JA; García Sáiz M
    Med Clin (Barc); 1993 Nov; 101(16):629-36. PubMed ID: 7505871
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.